Exencial Wealth Advisors, LLC Abbott Laboratories Transaction History

Exencial Wealth Advisors, LLC

$2.72 Billion
Q3 2024

A detailed history of Exencial Wealth Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 158,639 shares of ABT stock, worth $18.7 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

158,639

Previous 163,477 2.96%

Holding current value

$18.7 Million

Previous $17 Million 6.48%

% of portfolio

0.66%

Previous 0.65%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$100.07 - $118.13 $484,138 - $571,512	-4,838 Reduced 2.96%	158,639 $18.1 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $816,315 - $911,213	-8,104 Reduced 4.72%	163,477 $17 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $3.81 Million - $4.2 Million	34,746 Added 25.39%	171,581 $19.5 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $7.15 Million - $8.75 Million	79,263 Added 137.68%	136,835 $15.1 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $584,643 - $701,474	-6,120 Reduced 9.61%	57,572 $5.58 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $216,475 - $241,198	-2,148 Reduced 3.26%	63,692 $6.94 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $490,499 - $577,346	-5,064 Reduced 7.14%	65,840 $6.67 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $148,198 - $173,859	-1,559 Reduced 2.15%	70,904 $7.79 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $184,811 - $213,977	-1,910 Reduced 2.57%	72,463 $7.01 Million
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $233,638 - $282,393	-2,289 Reduced 2.99%	74,373 $8.08 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $219,146 - $267,234	-1,922 Reduced 2.45%	76,662 $9.07 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $2.92 Million - $3.57 Million	-25,235 Reduced 24.31%	78,584 $11.1 Million
Q3 2021 Nov 04, 2021	BUY	$116.66 - $129.06 $3.16 Million - $3.49 Million	27,077 Added 35.28%	103,819 $12.3 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $373,967 - $440,213	3,535 Added 4.83%	76,742 $8.9 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $400,313 - $471,629	3,678 Added 5.29%	73,207 $8.77 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $979,230 - $1.07 Million	-9,326 Reduced 11.83%	69,529 $7.61 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $596,668 - $724,609	6,511 Added 9.0%	78,855 $8.58 Million
Q2 2020 Aug 17, 2020	BUY	$76.57 - $98.0 $772,285 - $988,428	10,086 Added 16.2%	72,344 $6.61 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $355,184 - $519,376	5,654 Added 9.99%	62,258 $4.91 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $155,920 - $173,576	1,986 Added 3.64%	56,604 $4.92 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $28,807 - $31,236	352 Added 0.65%	54,618 $4.57 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $179,722 - $209,610	-2,466 Reduced 4.35%	54,266 $4.56 Million
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $42,513 - $51,398	-642 Reduced 1.12%	56,732 $4.54 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $172,685 - $195,627	2,634 Added 4.81%	57,374 $4.15 Million
Q3 2018 Nov 05, 2018	BUY	$60.81 - $73.36 $255,037 - $307,671	4,194 Added 8.3%	54,740 $4.02 Million
Q2 2018 Aug 01, 2018	BUY	$57.57 - $63.54 $160,620 - $177,276	2,790 Added 5.84%	50,546 $3.08 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $259,629 - $293,542	4,614 Added 10.69%	47,756 $2.86 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $19,056 - $20,401	355 Added 0.83%	43,142 $2.46 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $2.06 Million - $2.3 Million	42,787	42,787 $2.28 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.

Account

Exencial Wealth Advisors, LLC Abbott Laboratories Transaction History